FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124458344> ?p ?o ?g. }

• W2124458344 endingPage "1090" @default.
• W2124458344 startingPage "1083" @default.
• W2124458344 abstract "This European Group for Blood and Marrow Transplantation (EBMT) multicentre randomized phase III study was designed to assess the safety and efficacy of CD34+ selection in newly diagnosed myeloma patients undergoing autologous transplantation.One hundred and eleven patients responsive to initial chemotherapy were randomized to receive CD34+ selected (arm A) or unselected PBPC (arm B) after conditioning with high-dose melphalan and TBI. ASO-PCR was used to assess purging efficacy and reinfused tumor load. Tumor load could be assessed in 59 patients.CD34+ selection gave a median tumor cell depletion of 2.2 logs (0.77-5.96). No tumor cells were detected in products infused in 17/26 (A) and 5/33 (B) patients. The five year overall survival (OS), event free survival (EFS) and relapse rate (RR) were 51%, 20% and 80% in arm A and 45%, 18% and 80% in arm B respectively with no significant difference between the two groups. Thirteen patients in arm A and 2 in arm B experienced episodes of serious early infection (p=0.02). There were 3 early transplant related deaths in A but none in B.Despite significant tumor cell reduction, CD34+ selection does not reduce RR and increases the risk of severe post-transplant infections. There was also no difference in RR between patients in either arm who received grafts with detectable tumor cells and those receiving grafts with no detectable tumor cells, suggesting that reinfused tumor cells may not be the main cause of relapse after autologous transplant in myeloma." @default.
• W2124458344 created "2016-06-24" @default.
• W2124458344 creator A5010326744 @default.
• W2124458344 creator A5014322334 @default.
• W2124458344 creator A5018331182 @default.
• W2124458344 creator A5020002610 @default.
• W2124458344 creator A5026485141 @default.
• W2124458344 creator A5028365885 @default.
• W2124458344 creator A5029904007 @default.
• W2124458344 creator A5042734609 @default.
• W2124458344 creator A5045618273 @default.
• W2124458344 creator A5055916434 @default.
• W2124458344 creator A5066284854 @default.
• W2124458344 creator A5074115908 @default.
• W2124458344 creator A5078296677 @default.
• W2124458344 creator A5081603184 @default.
• W2124458344 creator A5086354986 @default.
• W2124458344 date "2007-08-01" @default.
• W2124458344 modified "2023-10-14" @default.
• W2124458344 title "Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study" @default.
• W2124458344 cites W1508505201 @default.
• W2124458344 cites W187373797 @default.
• W2124458344 cites W1922664920 @default.
• W2124458344 cites W1966573040 @default.
• W2124458344 cites W1969294339 @default.
• W2124458344 cites W1977390830 @default.
• W2124458344 cites W1978377409 @default.
• W2124458344 cites W1994865363 @default.
• W2124458344 cites W2005595638 @default.
• W2124458344 cites W2006897734 @default.
• W2124458344 cites W2038750132 @default.
• W2124458344 cites W2039847348 @default.
• W2124458344 cites W2043410355 @default.
• W2124458344 cites W2057046426 @default.
• W2124458344 cites W2060028114 @default.
• W2124458344 cites W2060881421 @default.
• W2124458344 cites W2061243005 @default.
• W2124458344 cites W2066969331 @default.
• W2124458344 cites W2075109253 @default.
• W2124458344 cites W2079893206 @default.
• W2124458344 cites W2080514807 @default.
• W2124458344 cites W2094051159 @default.
• W2124458344 cites W2098570489 @default.
• W2124458344 cites W2102811377 @default.
• W2124458344 cites W2107793675 @default.
• W2124458344 cites W2117648349 @default.
• W2124458344 cites W2119698149 @default.
• W2124458344 cites W2126485624 @default.
• W2124458344 cites W2127143739 @default.
• W2124458344 cites W2128608897 @default.
• W2124458344 cites W2158470148 @default.
• W2124458344 cites W2165718641 @default.
• W2124458344 cites W2208416639 @default.
• W2124458344 cites W2320834245 @default.
• W2124458344 cites W2326331137 @default.
• W2124458344 cites W2328274820 @default.
• W2124458344 cites W2410629884 @default.
• W2124458344 cites W2415404873 @default.
• W2124458344 cites W2416846259 @default.
• W2124458344 cites W2418641834 @default.
• W2124458344 cites W2421553863 @default.
• W2124458344 cites W2496544297 @default.
• W2124458344 cites W46462970 @default.
• W2124458344 cites W8070241 @default.
• W2124458344 cites W181450122 @default.
• W2124458344 cites W1982499121 @default.
• W2124458344 cites W2333363976 @default.
• W2124458344 doi "https://doi.org/10.3324/haematol.10535" @default.
• W2124458344 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17640853" @default.
• W2124458344 hasPublicationYear "2007" @default.
• W2124458344 type Work @default.
• W2124458344 sameAs 2124458344 @default.
• W2124458344 citedByCount "53" @default.
• W2124458344 countsByYear W21244583442012 @default.
• W2124458344 countsByYear W21244583442013 @default.
• W2124458344 countsByYear W21244583442014 @default.
• W2124458344 countsByYear W21244583442015 @default.
• W2124458344 countsByYear W21244583442016 @default.
• W2124458344 countsByYear W21244583442018 @default.
• W2124458344 countsByYear W21244583442019 @default.
• W2124458344 countsByYear W21244583442020 @default.
• W2124458344 countsByYear W21244583442021 @default.
• W2124458344 countsByYear W21244583442022 @default.
• W2124458344 countsByYear W21244583442023 @default.
• W2124458344 crossrefType "journal-article" @default.
• W2124458344 hasAuthorship W2124458344A5010326744 @default.
• W2124458344 hasAuthorship W2124458344A5014322334 @default.
• W2124458344 hasAuthorship W2124458344A5018331182 @default.
• W2124458344 hasAuthorship W2124458344A5020002610 @default.
• W2124458344 hasAuthorship W2124458344A5026485141 @default.
• W2124458344 hasAuthorship W2124458344A5028365885 @default.
• W2124458344 hasAuthorship W2124458344A5029904007 @default.
• W2124458344 hasAuthorship W2124458344A5042734609 @default.
• W2124458344 hasAuthorship W2124458344A5045618273 @default.
• W2124458344 hasAuthorship W2124458344A5055916434 @default.
• W2124458344 hasAuthorship W2124458344A5066284854 @default.
• W2124458344 hasAuthorship W2124458344A5074115908 @default.
• W2124458344 hasAuthorship W2124458344A5078296677 @default.

• next